- Home
- / TCI GENE
TCI GENE
Stock Price
NT$56.9
2024-10-29
Market Capitalization
NT$1.5 B
2024-10-28
Revenue
NT$273.6 M
FY, 2025
TCI GENE Summary
Company Summary
- Overview
- TCI GENE (大江基因醫學股份有限公司) is a company that provides health management solutions. It offers genetic testing and nutrition consultation services as well as delivers supplements.
- Type
- Public
- Status
- Active
- Founded
- 2011
- Website
- https://www.genext.me
Table of Contents
TCI GENE Financials
Summary Financials
- Revenue (FY, 2025)
- NT$273.6M
- Gross profit (FY, 2025)
- NT$164.9M
- Net income (FY, 2025)
- NT$39.1M
- Cash (FY, 2025)
- NT$250.7M
- EBIT (FY, 2025)
- (NT$16.6M)
- Enterprise value
- $1.3B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026